X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7214) 7214
Publication (511) 511
Book Review (120) 120
Book Chapter (41) 41
Newspaper Article (38) 38
Conference Proceeding (21) 21
Book / eBook (17) 17
Dissertation (13) 13
Trade Publication Article (7) 7
Web Resource (5) 5
Magazine Article (3) 3
Newsletter (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5629) 5629
female (3918) 3918
oncology (3717) 3717
index medicus (3552) 3552
chemotherapy (2850) 2850
middle aged (2737) 2737
platinum (2527) 2527
aged (2445) 2445
cancer (2329) 2329
antineoplastic combined chemotherapy protocols - therapeutic use (2259) 2259
adult (2189) 2189
male (2160) 2160
cisplatin (2055) 2055
antineoplastic agents - therapeutic use (1761) 1761
treatment outcome (1439) 1439
ovarian neoplasms - drug therapy (1396) 1396
ovarian cancer (1209) 1209
lung neoplasms - drug therapy (1156) 1156
animals (1145) 1145
carcinoma, non-small-cell lung - drug therapy (953) 953
platinum-based chemotherapy (933) 933
carcinoma (929) 929
care and treatment (928) 928
cisplatin - administration & dosage (907) 907
pharmacology & pharmacy (903) 903
prognosis (878) 878
aged, 80 and over (856) 856
neoplasm staging (840) 840
carboplatin (839) 839
survival (817) 817
paclitaxel (801) 801
cisplatin - therapeutic use (773) 773
disease-free survival (768) 768
antineoplastic combined chemotherapy protocols - adverse effects (713) 713
research (693) 693
retrospective studies (686) 686
ovarian neoplasms - pathology (658) 658
tumors (631) 631
cancer therapies (601) 601
survival rate (599) 599
survival analysis (588) 588
platinum compounds - therapeutic use (583) 583
lung cancer (560) 560
therapy (558) 558
analysis (553) 553
drug resistance, neoplasm (551) 551
toxicity (550) 550
platinum - therapeutic use (547) 547
patients (537) 537
carboplatin - administration & dosage (536) 536
mice (533) 533
obstetrics & gynecology (529) 529
lung neoplasms - pathology (516) 516
antineoplastic agents - pharmacology (515) 515
cell line, tumor (502) 502
hematology, oncology and palliative medicine (500) 500
neoplasms - drug therapy (487) 487
trial (484) 484
antineoplastic agents - adverse effects (481) 481
gemcitabine (472) 472
health aspects (467) 467
neoplasm recurrence, local - drug therapy (456) 456
apoptosis (448) 448
paclitaxel - administration & dosage (448) 448
drug therapy (442) 442
metastasis (431) 431
docetaxel (429) 429
deoxycytidine - analogs & derivatives (428) 428
antineoplastic agents - administration & dosage (424) 424
surgery (420) 420
carcinoma, non-small-cell lung - pathology (409) 409
lung cancer, non-small cell (408) 408
antineoplastic agents (405) 405
combined modality therapy (404) 404
clinical trials (399) 399
drug administration schedule (398) 398
medicine & public health (398) 398
organoplatinum compounds - therapeutic use (397) 397
follow-up studies (389) 389
phase-iii trial (384) 384
lung neoplasms - mortality (383) 383
phase-ii trial (383) 383
medicine (381) 381
article (375) 375
phase-ii (375) 375
cell lung-cancer (372) 372
gynecologic-oncology-group (369) 369
cisplatin - adverse effects (362) 362
carcinoma, squamous cell - drug therapy (355) 355
expression (337) 337
ovarian neoplasms - mortality (331) 331
carcinoma, non-small-cell lung - mortality (326) 326
cytotoxicity (326) 326
deoxycytidine - administration & dosage (324) 324
genetic aspects (323) 323
radiotherapy (323) 323
antimitotic agents (322) 322
drug resistance (321) 321
resistance (320) 320
multidisciplinary sciences (318) 318
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7168) 7168
Chinese (43) 43
Japanese (42) 42
French (30) 30
German (21) 21
Russian (16) 16
Spanish (8) 8
Polish (7) 7
Hungarian (5) 5
Czech (2) 2
Italian (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Dutch (1) 1
Lithuanian (1) 1
Portuguese (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2013, Volume 368, Issue 25, pp. 2385 - 2394
In a prospective, randomized, phase 3 trial of crizotinib as second-line therapy in patients who had disease progression while receiving a platinum-based... 
REARRANGEMENT | MEDICINE, GENERAL & INTERNAL | GEFITINIB | ONCOLOGY | EML4-ALK FUSION GENE | CLINICAL-TRIALS | PHASE-III | LYMPHOMA | OPEN-LABEL | DOCETAXEL | EGFR | Glutamates - therapeutic use | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Glutamates - adverse effects | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Young Adult | Taxoids - therapeutic use | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Guanine - adverse effects | Guanine - therapeutic use | Taxoids - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quality of Life | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Tyrosine | Intravenous administration | Biomedical research | Lung cancer | Liver | Fatigue | Chromosome rearrangements | Cancer therapies | Patients | Lymphoma | Metastases | Ovarian cancer | Quality of life | Confidence intervals | Chemotherapy | Dyspnea | Alopecia | Platinum | Lymphomas | Respiration | Pharmaceutical industry | Protein-tyrosine kinase
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 11, pp. 1015 - 1026
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 874 - 886
Journal Article
Journal Article